73C-29598-90984
2 vaccinations
4 coded responses
26 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 282 / NC
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-14
- 2021-01-18
-
2021-01-22
Dose 2 — Pfizer-BioNTech
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, DiarrheaAdult check-in
-
2021-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Urticaria — Feeling: Good · Site: PainFree text: Hives on left eyelidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
-
2021-02-26
Survey response — day 35, dose 2MedDRA: Pharyngitis streptococcal — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Strep throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-05
- 2021-04-23
-
2021-07-23
Survey response — 6 months, dose 2MedDRA: Urticaria — Feeling: GoodFree text: Hives on left eyelid that has not 100% resolved itselfMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-12-09
-
2022-01-22
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Currently have covidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-22 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-26 | Unsuccessful | |
| 2022-01-22 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Hives on left eyelid
Release 4 — day 35, dose 2
Symptoms: Strep throat
Release 9 — 6 months, dose 2
Symptoms: Hives on left eyelid that has not 100% resolved itself
Release 11 — 12 months, dose 2
Symptoms: Currently have covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pharyngitis streptococcal | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | · | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release